Drugs are a good example, and I would argue that the pesticide regulatory system is very analogous to the drug review and that the pre-market assessment is virtually identical in terms of requirements. In fact, we have an additional requirement because we have to do environmental fate as well, which drugs don't have to do.
In terms of adverse effects, this new act brought those requirements into legislation. Our members are obligated to provide any report that they get to PMRA. Also, any member of the public, doctors or anybody, can provide information as well, through the voluntary incident reporting systems.
Those measures are there. In fact, to characterize it as registering and then seeing what happens, I would say is not a fair characterization. I would say that your requirements on the pre-market assessment are extremely rigid and very analogous to the pharmaceutical world.